BioCardia, Inc. Income Taxes Receivable, Current
BioCardia, Inc. (BCDA) had Income Taxes Receivable, Current of $532.00 thousand as of 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Notes
us-gaap:IncomeTaxesReceivable · last filed 2012-11-08
- 2012-09-30: Income Taxes Receivable, Current $532.00K.
- 2011-12-31: Income Taxes Receivable, Current $0.00.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2012-09-30 | $532.00K 10-Q · filed 2012-11-08 |
| 2011-12-31 | $0.00 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |